Literature DB >> 2603926

Depressive episodes in premenstrual syndrome.

J F Mortola1, L Girton, S S Yen.   

Abstract

Episodic depression, a prominent but poorly defined symptom of premenstrual syndrome, was quantitated in 24-hour cortisol secretory episodes (determined by sampling at 20-minute intervals) as biochemical markers, as well as the Beck Depression Inventory and Profile of Mood States as psychometric measures. Results of 16 patients with premenstrual syndrome were compared with six age-matched women with endogenous depression and 16 control women. On both the Profile of Mood States and Beck Depression Inventory, women with premenstrual syndrome showed a marked worsening of scores (p less than 0.01) during the luteal phase compared with either their own follicular phase scores or the scores of controls in either cycle phase. However, Beck Depression Inventory scores were threefold higher (p less than 0.005) in women with depression than in those with luteal phase premenstrual syndrome (3.37 +/- 3.6 vs. 11.9 +/- 2.5). The Profile of Mood States depression scale was also higher (p less than 0.05) in women with depression than in those with premenstrual syndrome, while scores on other Profile of Mood States scales were similar. The numbers of cortisol secretory pulses identified by the cluster algorithm were similar (5 to 6 per 24 hours) in all groups, and the time of circadian nadirs as determined by cosinor rhythmometry were comparable. While the mean amplitude and duration of the cortisol pulses were also similar in women with premenstrual syndrome and controls, both were significantly higher (p less than 0.05) in women with depression. This resulted in markedly enhanced (p less than 0.005) cortisol secretion during a given secretory episode in women with depression and in higher 24-hour transverse mean cortisol values in women with depression (87.8 +/- 5.8 ng/ml) than in either those with premenstrual syndrome (66.7 +/- 3.3 ng/ml) or controls (58.9 +/- 3.3 ng/ml). These data affirm the clinical impression that depressive episodes occurring selectively in the luteal phase of the cycle in women with premenstrual syndrome are not present in controls and demonstrate, for the first time, that these episodes are distinct from endogenous depression as measured by both cortisol secretory parameters and psychological indices.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2603926     DOI: 10.1016/0002-9378(89)90950-2

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  8 in total

Review 1.  Problems related to menstruation amongst adolescent girls.

Authors:  Giridhara R Babu
Journal:  Indian J Pediatr       Date:  2010-02       Impact factor: 1.967

2.  ACTH and cortisol response to Dex/CRH testing in women with and without premenstrual dysphoria during GnRH agonist-induced hypogonadism and ovarian steroid replacement.

Authors:  Ellen E Lee; Lynnette K Nieman; Pedro E Martinez; Veronica L Harsh; David R Rubinow; Peter J Schmidt
Journal:  J Clin Endocrinol Metab       Date:  2012-03-30       Impact factor: 5.958

3.  Premenstrual dysphoric symptoms amongst Brazilian college students: factor structure and methodological appraisal.

Authors:  Chei-Tung Teng; Antônio Helio Guerra Vieira Filho; Rinaldo Artes; Clarice Gorenstein; Laura H Andrade; Yuan-Pang Wang
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2004-11-12       Impact factor: 5.270

Review 4.  Ovarian steroids and serotonin neural function.

Authors:  C L Bethea; M Pecins-Thompson; W E Schutzer; C Gundlah; Z N Lu
Journal:  Mol Neurobiol       Date:  1998-10       Impact factor: 5.590

5.  The impact of dysmenorrhea and premenstrual syndrome on academic performance of college students, and their willingness to seek help.

Authors:  Esra Bilir; Şule Yıldız; Kayhan Yakın; Barış Ata
Journal:  Turk J Obstet Gynecol       Date:  2020-10-02

6.  Ovarian steroid regulation of tryptophan hydroxylase mRNA expression in rhesus macaques.

Authors:  M Pecins-Thompson; N A Brown; S G Kohama; C L Bethea
Journal:  J Neurosci       Date:  1996-11-01       Impact factor: 6.167

7.  Safety, efficacy, actions, and patient acceptability of drospirenone/ethinyl estradiol contraceptive pills in the treatment of premenstrual dysphoric disorder.

Authors:  Lesley L Breech; Paula K Braverman
Journal:  Int J Womens Health       Date:  2010-08-09

8.  Plasma Interleukin-10 Levels Are Altered in Women with Severe Premenstrual Syndrome: A Preliminary Study.

Authors:  Kaori Yama; Yuki Asari; Aiko Ono; Maiko Machida; Jun Miura
Journal:  Womens Health Rep (New Rochelle)       Date:  2020-03-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.